Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

First case report of cryptococcosis due to Cryptococcus decagattii in a pediatric patient in Argentina.

Berejnoi A, Taverna CG, Mazza M, Vivot M, Isla G, Córdoba S, Davel G.

Rev Soc Bras Med Trop. 2019 Mar 28;52:e20180419. doi: 10.1590/0037-8682-0419-2018.

2.

Antifungal drug susceptibility and phylogenetic diversity among Cryptococcus isolates from dogs and cats in North America.

Singer LM, Meyer W, Firacative C, Thompson GR 3rd, Samitz E, Sykes JE.

J Clin Microbiol. 2014 Jun;52(6):2061-70. doi: 10.1128/JCM.03392-13. Epub 2014 Apr 2.

3.

Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.

Favalessa OC, de Paula DA, Dutra V, Nakazato L, Tadano T, Lazera Mdos S, Wanke B, Trilles L, Walderez Szeszs M, Silva D, Hahn RC.

J Infect Dev Ctries. 2014 Aug 13;8(8):1037-43. doi: 10.3855/jidc.4446.

4.

Environmental sampling of Ceratonia siliqua (carob) trees in Spain reveals the presence of the rare Cryptococcus gattii genotype AFLP7/VGIV.

Linares C, Colom MF, Torreblanca M, Esteban V, Romera Á, Hagen F.

Rev Iberoam Micol. 2015 Oct-Dec;32(4):269-72. doi: 10.1016/j.riam.2014.11.002. Epub 2015 Feb 27.

PMID:
25900707
5.

Evaluation of antifungal combination against Cryptococcus spp.

Reichert-Lima F, Busso-Lopes AF, Lyra L, Peron IH, Taguchi H, Mikami Y, Kamei K, Moretti ML, Schreiber AZ.

Mycoses. 2016 Sep;59(9):585-93. doi: 10.1111/myc.12510. Epub 2016 May 2.

PMID:
27135278
6.

Molecular Characterization and Antifungal Susceptibility Testing of Sequentially Obtained Clinical Cryptococcus deneoformans and Cryptococcus neoformans Isolates from Ljubljana, Slovenia.

Tomazin R, Matos T, Meis JF, Hagen F.

Mycopathologia. 2018 Apr;183(2):371-380. doi: 10.1007/s11046-017-0214-9. Epub 2017 Oct 24.

PMID:
29064061
7.

Molecular characterisation of the causative agents of Cryptococcosis in patients of a tertiary healthcare facility in the state of Amazonas-Brazil.

Freire AK, dos Santos Bentes A, de Lima Sampaio I, Matsuura AB, Ogusku MM, Salem JI, Wanke B, de Souza JV.

Mycoses. 2012 May;55(3):e145-50. doi: 10.1111/j.1439-0507.2012.02173.x. Epub 2012 Feb 24.

PMID:
22360142
8.

Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.

Hagen F, Hare Jensen R, Meis JF, Arendrup MC.

Mycoses. 2016 Sep;59(9):576-84. doi: 10.1111/myc.12507. Epub 2016 Apr 8.

PMID:
27061834
9.

Ferrets as sentinels of the presence of pathogenic Cryptococcus species in the Mediterranean environment.

Morera N, Hagen F, Juan-Sallés C, Artigas C, Patricio R, Serra JI, Colom MF.

Mycopathologia. 2014 Aug;178(1-2):145-51. doi: 10.1007/s11046-014-9773-1. Epub 2014 Jun 25.

PMID:
24962111
10.

Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.

Herkert PF, Hagen F, de Oliveira Salvador GL, Gomes RR, Ferreira MS, Vicente VA, Muro MD, Pinheiro RL, Meis JF, Queiroz-Telles F.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1803-1810. Epub 2016 Aug 1.

PMID:
27477855
11.

Identification of Disseminated Cryptococcosis Using MALDI-TOF MS and Clinical Evaluation.

Tarumoto N, Sakai J, Kodana M, Kawamura T, Ohno H, Maesaki S.

Med Mycol J. 2016;57(3):E41-6. doi: 10.3314/mmj.16-00002.

12.

Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

Espinel-Ingroff A, Aller AI, Canton E, Castañón-Olivares LR, Chowdhary A, Cordoba S, Cuenca-Estrella M, Fothergill A, Fuller J, Govender N, Hagen F, Illnait-Zaragozi MT, Johnson E, Kidd S, Lass-Flörl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, St-Germain G, Trilles L, Turnidge J.

Antimicrob Agents Chemother. 2012 Nov;56(11):5898-906. doi: 10.1128/AAC.01115-12. Epub 2012 Sep 4.

13.

[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].

Lei Y, Xiao YL, He C, Zhang CY, Xie Y, Kang M.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Jan;46(1):82-6. Chinese.

PMID:
25807801
14.
15.

Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.

Feng X, Yao Z, Ren D, Liao W, Wu J.

FEMS Yeast Res. 2008 Sep;8(6):930-8. doi: 10.1111/j.1567-1364.2008.00422.x. Epub 2008 Jul 29.

16.
17.

Insights on the genotype distribution among Cryptococcus neoformans and C. gattii Portuguese clinical isolates.

Maduro AP, Mansinho K, Teles F, Silva I, Meyer W, Martins ML, Inácio J.

Curr Microbiol. 2014 Feb;68(2):199-203.

PMID:
24077953
18.

Molecular typing of IberoAmerican Cryptococcus neoformans isolates.

Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E; IberoAmerican Cryptococcal Study Group.

Emerg Infect Dis. 2003 Feb;9(2):189-95.

19.

Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan.

Mihara T, Izumikawa K, Kakeya H, Ngamskulrungroj P, Umeyama T, Takazono T, Tashiro M, Nakamura S, Imamura Y, Miyazaki T, Ohno H, Yamamoto Y, Yanagihara K, Miyzaki Y, Kohno S.

Med Mycol. 2013 Apr;51(3):252-60. doi: 10.3109/13693786.2012.708883. Epub 2012 Aug 17.

PMID:
22901045
20.

MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors.

Firacative C, Roe CC, Malik R, Ferreira-Paim K, Escandón P, Sykes JE, Castañón-Olivares LR, Contreras-Peres C, Samayoa B, Sorrell TC, Castañeda E, Lockhart SR, Engelthaler DM, Meyer W.

PLoS Negl Trop Dis. 2016 Aug 5;10(8):e0004861. doi: 10.1371/journal.pntd.0004861. eCollection 2016 Aug.

Supplemental Content

Support Center